176 related articles for article (PubMed ID: 17662025)
1. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma.
Bachert C; Fimmel C; Linstedt AD
Traffic; 2007 Oct; 8(10):1415-23. PubMed ID: 17662025
[TBL] [Abstract][Full Text] [Related]
2. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
3. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
4. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
[TBL] [Abstract][Full Text] [Related]
6. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
8. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
9. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
Ba MC; Long H; Tang YQ; Cui SZ
Int J Clin Exp Pathol; 2012; 5(9):874-81. PubMed ID: 23119104
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of golgi protien-73 and DICKKOPF-1 in hepatocellular carcinoma.
ElZefzafy WM; Hussien M; Mohmmed ZAZ; Abd Elbaky NM
J Immunoassay Immunochem; 2021 Mar; 42(2):174-187. PubMed ID: 33284721
[TBL] [Abstract][Full Text] [Related]
12. [Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology].
Wu Y; Wang YP; Ma J; Zhang YH; Sun HQ; Sun JP; Wang ZK; Xu J; Dai YC; Li N
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):351-356. PubMed ID: 31137168
[No Abstract] [Full Text] [Related]
13. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X
Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213
[TBL] [Abstract][Full Text] [Related]
14. Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma.
Wang C; Hua-yu Y; Yi-lei M; Jin-chun Z; Hai-feng X; Gui-yong J; Yan-ling J; Xin-xin C; Xin L; Xin-ting S; Hong-bing Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):39-44. PubMed ID: 21375936
[TBL] [Abstract][Full Text] [Related]
15. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value and clinical significance of the Golgi protein-73 in hepatocellular carcinoma].
Shi QF; Pan XD; Zhang WG; Shao WF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):480-2. PubMed ID: 23627036
[TBL] [Abstract][Full Text] [Related]
19. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.
Sun Y; Yang H; Mao Y; Xu H; Zhang J; Li G; Lu X; Sang X; Zhao H; Zhong S; Huang J; Zhang H
J Gastroenterol Hepatol; 2011 Jul; 26(7):1207-12. PubMed ID: 21443671
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
